Showing posts with label Big Pharma. Show all posts
Showing posts with label Big Pharma. Show all posts

Oct 6, 2020

Jon Rappaport on Trump's experimental treatments at Walter Reed Medical Center

The combined effects of these two medicines [Remdesivir and Regeneron] have never been studied in depth. Nevertheless, the Walter Reed doctors treated the president of the United States with both of them. Their hypothesis seemed to be: if a little bit of medicine is good, a lot will be better. Needless to say, this approach has never been backed by science at any time. It is reckless in the extreme. And now we learn about a third drug, dexamethasone. 

[...]

And now, since the Walter Reed doctors are treating Trump with three drugs, they are ignoring the fact that the combined effects of these three have never been studied in depth. More reckless experimentation. Naturally, any decline in the president’s health will be attributed to “COVID-19,” not the drugs.  

[...]

[D]octors have violated the most basic principles of the healing profession. They are endangering the president’s health and life. People who view “leading doctors” as unshakable symbols of good science, and avid Trump supporters who believe the president is far too brilliant to submit himself to these dangerous drugs…need to rethink their positions. If they dare.




Jul 31, 2014

Bill Ackman on the price drop in Valeant Pharmaceuticals

At this price, it's a gift to investors.

~ Bill Ackman, as appeared on CNBC, July 31, 2014

(Valeant stock was trading at about $120, down from previous close of $125.83.  VRX was selling off after release of Q2 earnings.)

Feb 18, 2011

Jim Cramer on the prospects for Big Pharma

It's just one big expensive graveyard of stocks if you ask me. For those who own, or are thinking of owning one of these names -- I'm talking about Merck, Bristol-Myers, Eli Lilly, Pfizer, GlaxoSmithKline or the ultimate dog of the drug stocks, Johnson & Johnson, with its Wall of Shame'r CEO -- it's time to recognize that these stocks aren't as defensive as they used to be, not by a long shot. It's the twilight of the Big Pharma idols, and you need to be ready for it.

All of these companies are about to fall off big patent cliffs as many of the blockbusters go generic. You know what it's like when you go to the drugstore and it's a lot of money, like $400, and the next day it's $15, that's going generic. It's incredibly difficult to find new blockbusters to replace them. The drug companies have all been insisting their drug pipelines will be able to offset some of the damage from patent expiration. They say that over and over, they come on TV and say it and it's not working.

~Jim Cramer, CNBC's Mad Money with Jim Cramer, February 17, 2011